Infinity Pharmaceuticals Stock Buy Hold or Sell Recommendation
| INFIQ Stock | 0.0001 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Infinity Pharmaceuticals is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Infinity Pharmaceuticals given historical horizon and risk tolerance towards Infinity Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Infinity Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Infinity Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Infinity Stock, please use our How to Invest in Infinity Pharmaceuticals guide. Note, we conduct extensive research on individual companies such as Infinity and provide practical buy, sell, or hold advice based on investors' constraints. Infinity Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Infinity |
Execute Infinity Pharmaceuticals Buy or Sell Advice
The Infinity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Infinity Pharmaceuticals. Macroaxis does not own or have any residual interests in Infinity Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Infinity Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Infinity Pharmaceuticals Trading Alerts and Improvement Suggestions
| Infinity Pharmaceuticals generated a negative expected return over the last 90 days | |
| Infinity Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Infinity Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M). | |
| Infinity Pharmaceuticals generates negative cash flow from operations | |
| Latest headline from kalkinemedia.com: Axie Infinity price could surge 50 percent amid the network renaissance |
Infinity Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Infinity Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Infinity Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Infinity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Infinity Pharmaceuticals Volatility Alert
At this time Infinity Pharmaceuticals exhibits very low volatility. Infinity Pharmaceuticals appears to be a penny stock. Although Infinity Pharmaceuticals may be, in fact, a solid short-term or long term investment, many penny stocks are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Infinity Pharmaceuticals or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Infinity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Infinity Pharmaceuticals Fundamentals Vs Peers
Comparing Infinity Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Infinity Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Infinity Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Infinity Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Infinity Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Infinity Pharmaceuticals to competition |
| Fundamentals | Infinity Pharmaceuticals | Peer Average |
| Return On Asset | -0.61 | -0.14 |
| Operating Margin | (17.36) % | (5.51) % |
| Current Valuation | (17.1 M) | 16.62 B |
| Shares Outstanding | 90.76 M | 571.82 M |
| Shares Owned By Insiders | 2.68 % | 10.09 % |
| Number Of Shares Shorted | 2.21 M | 4.71 M |
| Price To Book | 8.03 X | 9.51 X |
| Price To Sales | 0 X | 11.42 X |
| Revenue | 2.59 M | 9.43 B |
| Gross Profit | (31.38 M) | 27.38 B |
| EBITDA | (43.73 M) | 3.9 B |
| Net Income | (44.37 M) | 570.98 M |
| Total Debt | 917 K | 5.32 B |
| Book Value Per Share | (0.41) X | 1.93 K |
| Cash Flow From Operations | (42.43 M) | 971.22 M |
| Short Ratio | 0.31 X | 4.00 X |
| Earnings Per Share | (0.46) X | 3.12 X |
| Target Price | 0.3 | |
| Number Of Employees | 30 | 18.84 K |
| Beta | 1.33 | -0.15 |
| Market Capitalization | 9.08 K | 19.03 B |
| Total Asset | 42.15 M | 29.47 B |
| Retained Earnings | (855.95 M) | 9.33 B |
| Working Capital | 26.67 M | 1.48 B |
| Net Asset | 42.15 M |
Infinity Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Infinity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Infinity Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Infinity Pharmaceuticals? Buying financial instruments such as Infinity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Infinity Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.